RecruitingPHASE1, PHASE2NCT05586581

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

Studying Encephalitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yale University
Principal Investigator
Serena Spudich, MD
Yale University
Intervention
SV2A PET(drug)
Enrollment
70 enrolled
Eligibility
18-80 years · All sexes
Timeline
20232030

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Institute of Mental Health (NIMH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05586581 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis

← Back to all trials